주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
239 )
기사목록 보기 형태
제목형
요약형
포토형
Will Celltrion CEO’s bet on ‘bio valley’ pay off?
Jeong Sae-im
2019.05.17 11:44
CHA Biotech’s operating income plunges 92% in Q1
Jeong Sae-im
2019.05.16 13:29
KangStem Biotech completes stem cell drug plant
Jeong Sae-im
2019.05.16 11:20
Samsung BioLogics in tight spot amid probe, shareholders’ lawsuit
Jeong Sae-im
2019.05.14 14:07
‘MSD Korea’s foreign exec got drunk, sexually harassed female worker’
Jeong Sae-im
2019.05.14 11:27
Celltrion’s operating income down 33% in Q1
Jeong Sae-im
2019.05.09 15:16
If Invossa license gets revoked, Kolon should return $13 million to Mundipharma
Jeong Sae-im
2019.05.08 15:33
Mobile healthcare firm Noom raises $58 million for biz expansion
Jeong Sae-im
2019.05.08 14:20
Inspection will clear all suspicions over Invossa: TissueGene
Jeong Sae-im
2019.05.08 11:24
Kolon might have covered up Invossa mislabeling for 2 years
Jeong Sae-im
2019.05.07 15:17
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave
Jeong Sae-im
2019.05.07 11:58
Civic group files complaint against Kolon, regulator
Jeong Sae-im
2019.04.30 14:47
처음
이전
이전
이전
11
12
13
14
15
16
17
18
19
20
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기